Drug-drug competition as one of the reasons of inefficiency and side effects of medications.
O.B. Vorozhbit, R.Yu Hrytsko, O.B. Herasun
Basic schemes and new approaches to the treatment of autoimmune hepatitis (literature data and own observations).
K.O. Kondratiuk, P.N. Bodnar, N.I. Lisyany, L.N Belska
Influence of probiotic therapy and hepatoprotection on levels of proinflammatory cytokines and endotoxemia in patients with diabetes mellitus type 2 and non-alcoholic fatty liver disease.
L.V.Moroz, O.S. Androsova, S.M.Antonyak
Morphological peculiarities of liver damage in hiv-infected patients.
O.S. Sovirda, E.A. Gerasimenko, E.V. Kozshkurt, І.V. Ashanina, G.F. Kovalskaya, T.V. Fedorenko
The effect of hepa -merz on the content of amp in red blood cells of patients with severe acute hepatitis B.
V.M. Kozko, O.Ye. Bondar, G.O. Solomennyk, N.V. Antsyferova, L.M. Amelina, D.B. Penkov
Prognosis of effectiveness and choice of antiviral therapy tactics in patients with chronic hepatitis C.
To help practitioner
S. Fedorchenko, T. Martynovych, O. Lyashok, Z. Klymenko, V. Yanchenko, V. Reznyk
Tenofovir is effective in development of HBV resistance to lamivudine (m 204 i motif mutation) and to interferon/ pegylated interferon in patients with chronic HBeAg- negative hepatitis B.